Cargando…

Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis

Systemic ATTR amyloidosis is an increasingly important protein misfolding disease that is provoked by the formation of amyloid fibrils from transthyretin protein. The pathological and clinical disease manifestations and the number of pathogenic mutational changes in transthyretin are highly diverse,...

Descripción completa

Detalles Bibliográficos
Autores principales: Steinebrei, Maximilian, Baur, Julian, Pradhan, Anaviggha, Kupfer, Niklas, Wiese, Sebastian, Hegenbart, Ute, Schönland, Stefan O., Schmidt, Matthias, Fändrich, Marcus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665346/
https://www.ncbi.nlm.nih.gov/pubmed/37993462
http://dx.doi.org/10.1038/s41467-023-43301-3
_version_ 1785148849635983360
author Steinebrei, Maximilian
Baur, Julian
Pradhan, Anaviggha
Kupfer, Niklas
Wiese, Sebastian
Hegenbart, Ute
Schönland, Stefan O.
Schmidt, Matthias
Fändrich, Marcus
author_facet Steinebrei, Maximilian
Baur, Julian
Pradhan, Anaviggha
Kupfer, Niklas
Wiese, Sebastian
Hegenbart, Ute
Schönland, Stefan O.
Schmidt, Matthias
Fändrich, Marcus
author_sort Steinebrei, Maximilian
collection PubMed
description Systemic ATTR amyloidosis is an increasingly important protein misfolding disease that is provoked by the formation of amyloid fibrils from transthyretin protein. The pathological and clinical disease manifestations and the number of pathogenic mutational changes in transthyretin are highly diverse, raising the question whether the different mutations may lead to different fibril morphologies. Using cryo-electron microscopy, however, we show here that the fibril structure is remarkably similar in patients that are affected by different mutations. Our data suggest that the circumstances under which these fibrils are formed and deposited inside the body - and not only the fibril morphology - are crucial for defining the phenotypic variability in many patients.
format Online
Article
Text
id pubmed-10665346
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-106653462023-11-22 Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis Steinebrei, Maximilian Baur, Julian Pradhan, Anaviggha Kupfer, Niklas Wiese, Sebastian Hegenbart, Ute Schönland, Stefan O. Schmidt, Matthias Fändrich, Marcus Nat Commun Article Systemic ATTR amyloidosis is an increasingly important protein misfolding disease that is provoked by the formation of amyloid fibrils from transthyretin protein. The pathological and clinical disease manifestations and the number of pathogenic mutational changes in transthyretin are highly diverse, raising the question whether the different mutations may lead to different fibril morphologies. Using cryo-electron microscopy, however, we show here that the fibril structure is remarkably similar in patients that are affected by different mutations. Our data suggest that the circumstances under which these fibrils are formed and deposited inside the body - and not only the fibril morphology - are crucial for defining the phenotypic variability in many patients. Nature Publishing Group UK 2023-11-22 /pmc/articles/PMC10665346/ /pubmed/37993462 http://dx.doi.org/10.1038/s41467-023-43301-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Steinebrei, Maximilian
Baur, Julian
Pradhan, Anaviggha
Kupfer, Niklas
Wiese, Sebastian
Hegenbart, Ute
Schönland, Stefan O.
Schmidt, Matthias
Fändrich, Marcus
Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis
title Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis
title_full Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis
title_fullStr Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis
title_full_unstemmed Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis
title_short Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis
title_sort common transthyretin-derived amyloid fibril structures in patients with hereditary attr amyloidosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665346/
https://www.ncbi.nlm.nih.gov/pubmed/37993462
http://dx.doi.org/10.1038/s41467-023-43301-3
work_keys_str_mv AT steinebreimaximilian commontransthyretinderivedamyloidfibrilstructuresinpatientswithhereditaryattramyloidosis
AT baurjulian commontransthyretinderivedamyloidfibrilstructuresinpatientswithhereditaryattramyloidosis
AT pradhananaviggha commontransthyretinderivedamyloidfibrilstructuresinpatientswithhereditaryattramyloidosis
AT kupferniklas commontransthyretinderivedamyloidfibrilstructuresinpatientswithhereditaryattramyloidosis
AT wiesesebastian commontransthyretinderivedamyloidfibrilstructuresinpatientswithhereditaryattramyloidosis
AT hegenbartute commontransthyretinderivedamyloidfibrilstructuresinpatientswithhereditaryattramyloidosis
AT schonlandstefano commontransthyretinderivedamyloidfibrilstructuresinpatientswithhereditaryattramyloidosis
AT schmidtmatthias commontransthyretinderivedamyloidfibrilstructuresinpatientswithhereditaryattramyloidosis
AT fandrichmarcus commontransthyretinderivedamyloidfibrilstructuresinpatientswithhereditaryattramyloidosis